Category: Regulation and Deregulation of Industry

E.P.A. Retreats From Plans to End the Energy Star Program

The agency has faced blowback from business leaders and Republicans over plans to end the popular energy efficiency program.
Trump Administration Seeks to Return Medical Debt to Credit Reports

A federal rule restricting the debt’s inclusion has been canceled. Now, the consumer bureau is trying to overturn state restrictions.
In China Truce on Tariffs and Rare Earths, National Security Controls Are Bargaining Chip

Some analysts say Beijing won a major victory in its trade talks: Getting the U.S. to withdraw a national security measure that previously was not under discussion.
F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs

The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs.
What to know about the Fed meeting.

The U.S. central bank is widely expected to cut interest rates for the second meeting in a row even though the government shutdown is obscuring officials’ view of the economy.
What to Watch at the Federal Reserve’s October Meeting

The U.S. central bank is widely expected to cut interest rates for the second meeting in a row even though the government shutdown is obscuring officials’ view of the economy.
Texas Sues Tylenol Makers, Claiming They Hid Autism Risks

The lawsuit follows claims by President Trump that linked use by pregnant women of acetaminophen to autism, a connection that is unproven.
Fed’s Policy Path Looks More Treacherous as Shutdown Delays Critical Data

The central bank is poised to lower interest rates again on Wednesday despite having only a partial view of how the economy is faring.
Strains in Short-Term Markets Raise Urgency of Fed Balance Sheet Debate

Warning signs in crucial money markets have raised the prospect that the central bank will soon stop reducing its portfolio of government debt and mortgage bond holdings.
Fed Prepares Bank-Friendly Changes to Annual Stress Tests

The Federal Reserve Board is poised to start releasing in advance models it uses to test the biggest banks’ readiness to withstand economic shocks.
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices

In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.
Hoping to Grow in Europe, but Bogged Down by Red Tape

Start-ups are booming in the European Union, but experts say bureaucracy keeps them from expanding across borders.